CIMT 2016: Mechanisms of efficacy in cancer immunotherapy - Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10-12 2016, Mainz, Germany

Lena M Kranz; Matthias Birtel; Lina Hilscher; Christian Grunwitz; Jutta Petschenka; Fulvia Vascotto; Mathias Vormehr; Ralf-Holger Voss; Sebastian Kreiter; Mustafa Diken

doi:10.1080/21645515.2016.1206677

CIMT 2016: Mechanisms of efficacy in cancer immunotherapy - Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10-12 2016, Mainz, Germany

Hum Vaccin Immunother. 2016 Nov;12(11):2805-2812. doi: 10.1080/21645515.2016.1206677. Epub 2016 Jul 19.

Authors

Lena M Kranz^{1

2}, Matthias Birtel^{1

2}, Lina Hilscher¹, Christian Grunwitz^{1

3}, Jutta Petschenka¹, Fulvia Vascotto¹, Mathias Vormehr^{1

3}, Ralf-Holger Voss¹, Sebastian Kreiter¹, Mustafa Diken¹

Affiliations

¹ a TRON-Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH , Mainz , Germany.
² b Research Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg University , Mainz , Germany.
³ c BioNTech RNA Pharmaceuticals GmbH , Mainz , Germany.

No abstract available

Keywords: CIMT; antibodies; cancer immunotherapy; cellular therapy; checkpoint blockade; combination therapy; personalized therapy; tumor microenvironment; tumor vaccination.

Publication types

Congress

MeSH terms

Germany
Humans
Immunotherapy / methods*
Neoplasms / therapy*